Björn Andréasson (Björn Andreasson)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Topics

Replacement Therapy

Patient Reported Outcomes

Ejection Fraction

Top Venues

European journal of haematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Anneli Enblom Larsson, Björn Andréasson, Henrik Holmberg, Maria Liljeholm, Anders Själander
Erythrocytosis, Thrombocytosis and Rate of Recurrent Thromboembolic Event - A Population Based Cohort Study. European journal of haematology (2023)
Anneli Enblom Larsson, Björn Andréasson, Henrik Holmberg, Maria Liljeholm, Anders Själander
Erythrocytosis, thrombocytosis, and rate of recurrent thromboembolic event-A population based cohort study. European journal of haematology (2023)
Björn Andréasson, Helna Pettersson, Carina Wasslavik, Peter Johansson, Lars Palmqvist, Julia Asp
ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO-defined polycythaemia vera patients. British journal of haematology 189 (5) (2020)
Erik Ahlstrand, Jan Samuelsson, Marie Lindgren, Helna Pettersson, Maria Liljeholm, Anna Ravn-Landtblom, Stefan Scheding, Björn Andréasson
Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow-up. European journal of haematology 104 (3) (2020)
Gunnar Birgegard, Jan Samuelsson, Erik Ahlstrand, Elisabeth Ejerblad, Christian Enevold, Waleed Ghanima, Hans Hasselbalch, Claus H Nielsen, Håvar Knutsen, Ole B Pedersen, Anders Sørensen, Björn Andréasson
Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study Group. European journal of haematology 102 (3) (2019)
Marie Lindgren, Jan Samuelsson, Lars Nilsson, Håvar Knutsen, Waleed Ghanima, Johan Westin, Peter L Johansson, Björn Andréasson
Genetic variation in IL28B (IFNL3) and response to interferon-alpha treatment in myeloproliferative neoplasms. European journal of haematology 100 (5) (2018)
Khadija Abdulkarim, Jan Samuelsson, Peter Johansson, Björn Andréasson
Risk factors for vascular complications and treatment patterns at diagnosis of 2389 PV and ET patients: Real-world data from the Swedish MPN Registry. European journal of haematology 98 (6) (2017)